CAR T-cell therapy for paediatric solid tumours: clinical trial development and preclinical modelling
Feb 18, 2026
TTCI Hosts Special Lecture on CAR T-Cell Therapy for Paediatric Solid Tumours
The Thailand Hub of Talents in Cancer Immunotherapy (TTCI) recently had the honor of hosting a distinguished guest and expert in the field of paediatric oncology, Professor Geraldine O’Neill.
On Wednesday, 18 February 2026, Professor O’Neill—Head of the Children’s Cancer Research Unit at The Children’s Hospital at Westmead and Conjoint Professor at the University of Sydney—delivered an insightful lecture titled: "CAR T-Cell Therapy for Paediatric Solid Tumours: Clinical Trial Development and Preclinical Modelling" Key Highlights of the Visit Scientific Exchange: The session, held at the Theater Room of the Faculty of Medicine Library, Chulalongkorn University, brought together researchers, clinicians, and students to discuss the complexities of treating solid tumours in children using advanced cell engineering.
Facility Tour: Professor O’Neill visited our state-of-the-art Cell and Gene Therapy Manufacturing Center and the Chula Vaccine Research Center. She engaged with the TTCI team to discuss current workflows and the "Chula CAR T-Cell Program." Strengthening Global Networks: This visit underscores TTCI’s mission to foster international collaboration, sharing cutting-edge preclinical models and clinical trial strategies to improve outcomes for young cancer patients in Thailand and beyond. We extend our sincere thanks to Professor O'Neill for her time and for sharing her invaluable expertise with our community.
On Wednesday, 18 February 2026, Professor O’Neill—Head of the Children’s Cancer Research Unit at The Children’s Hospital at Westmead and Conjoint Professor at the University of Sydney—delivered an insightful lecture titled: "CAR T-Cell Therapy for Paediatric Solid Tumours: Clinical Trial Development and Preclinical Modelling" Key Highlights of the Visit Scientific Exchange: The session, held at the Theater Room of the Faculty of Medicine Library, Chulalongkorn University, brought together researchers, clinicians, and students to discuss the complexities of treating solid tumours in children using advanced cell engineering.
Facility Tour: Professor O’Neill visited our state-of-the-art Cell and Gene Therapy Manufacturing Center and the Chula Vaccine Research Center. She engaged with the TTCI team to discuss current workflows and the "Chula CAR T-Cell Program." Strengthening Global Networks: This visit underscores TTCI’s mission to foster international collaboration, sharing cutting-edge preclinical models and clinical trial strategies to improve outcomes for young cancer patients in Thailand and beyond. We extend our sincere thanks to Professor O'Neill for her time and for sharing her invaluable expertise with our community.
